2R9C image
Deposition Date 2007-09-12
Release Date 2008-08-26
Last Version Date 2023-08-30
Entry Detail
PDB ID:
2R9C
Keywords:
Title:
Calpain 1 proteolytic core inactivated by ZLAK-3001, an alpha-ketoamide
Biological Source:
Source Organism:
Rattus norvegicus (Taxon ID: )
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.19
R-Value Work:
0.15
R-Value Observed:
0.15
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Calpain-1 catalytic subunit
Gene (Uniprot):Capn1
Chain IDs:A
Chain Length:339
Number of Molecules:1
Biological Source:Rattus norvegicus
Primary Citation
Cocrystal structures of primed side-extending alpha-ketoamide inhibitors reveal novel calpain-inhibitor aromatic interactions.
J.Med.Chem. 51 5264 5270 (2008)
PMID: 18702462 DOI: 10.1021/jm800045t

Abstact

Calpains are intracellular cysteine proteases that catalyze the cleavage of target proteins in response to Ca(2+) signaling. When Ca(2+) homeostasis is disrupted, calpain overactivation causes unregulated proteolysis, which can contribute to diseases such as postischemic injury and cataract formation. Potent calpain inhibitors exist, but of these many cross-react with other cysteine proteases and will need modification to specifically target calpain. Here, we present crystal structures of rat calpain 1 protease core (muI-II) bound to two alpha-ketoamide-based calpain inhibitors containing adenyl and piperazyl primed-side extensions. An unexpected aromatic-stacking interaction is observed between the primed-side adenine moiety and the Trp298 side chain. This interaction increased the potency of the inhibitor toward muI-II and heterodimeric m-calpain. Moreover, stacking orients the adenine such that it can be used as a scaffold for designing novel primed-side address regions, which could be incorporated into future inhibitors to enhance their calpain specificity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures